Volume 15 (2017): Issue 10 (Oct 2017)

in Journal of the National Comprehensive Cancer Network
Online ISSN:
1540-1413
Print ISSN:
1540-1405
Cover Journal of the National Comprehensive Cancer Network
NCCN News
Pages: xxxiii–xxxv
Oncology Research Program
Pages: xl
Serving “a la CAR-T”: Value-Based Pricing and Gene Therapy
By: Margaret Tempero
Pages: 1179
Implementation Framework for NCCN Guidelines
By: Abdul Rahman Jazieh, Joan S. McClure, and Robert W. Carlson
Pages: 1180–1185
To the Editor: Predictive Markers and Precision Medicine
By: Steven Sorscher
Pages: 1186
EGFR-Mutant Non–Small Cell Lung Cancer in the Era of Precision Medicine: Importance of Germline EGFR T790M Testing
By: Ammar Sukari, Misako Nagasaka, and Erin Wakeling
Pages: 1188–1192
NCCN Guidelines Insights: Myeloproliferative Neoplasms, Version 2.2018
By: Ruben A. Mesa, Catriona Jamieson, Ravi Bhatia, Michael W. Deininger, Christopher D. Fletcher, Aaron T. Gerds, Ivana Gojo, Jason Gotlib, Krishna Gundabolu, Gabriela Hobbs, Brandon McMahon, Sanjay R. Mohan, Stephen Oh, Eric Padron, Nikolaos Papadantonakis, Philip Pancari, Nikolai Podoltsev, Raajit Rampal, Erik Ranheim, Vishnu Reddy, Lindsay A.M. Rein, Bart Scott, David S. Snyder, Brady L. Stein, Moshe Talpaz, Srdan Verstovsek, Martha Wadleigh, Eunice S. Wang, Mary Anne Bergman, Kristina M. Gregory, and Hema Sundar
Pages: 1193–1207
The Senior Toronto Oncology Panel (STOP) Study: Research Participation for Older Adults With Cancer and Caregivers
By: Martine T.E. Puts, Schroder Sattar, Takami Fossat, Margaret I. Fitch, Geraldine J. Macdonald, Tina Hsu, Ewa Szumacher, Douglas A. Stephens, Joseph Robinson, David Macdonald, Andrew S. Choate, Eric Pitters, Barbara Liu, Lianne Jeffs, Katherine S. McGilton, and Shabbir M.H. Alibhai
Pages: 1208–1215
Pathologic Complete Response After Neoadjuvant Chemotherapy and Long-Term Outcomes Among Young Women With Breast Cancer
By: Laura Spring, Rachel Greenup, Andrzej Niemierko, Lidia Schapira, Stephanie Haddad, Rachel Jimenez, Suzanne Coopey, Alphonse Taghian, Kevin S. Hughes, Steven J. Isakoff, Leif W. Ellisen, Barbara L. Smith, Michelle Specht, Beverly Moy, and Aditya Bardia
Pages: 1216–1223
Distress and Financial Distress in Adults With Cancer: An Age-Based Analysis
By: Caitlin R. Meeker, Yu-Ning Wong, Brian L. Egleston, Michael J. Hall, Elizabeth R. Plimack, Lainie P. Martin, Margaret von Mehren, Bianca R. Lewis, and Daniel M. Geynisman
Pages: 1224–1233
A Population-Based Assessment of Emergency Department Observation Status for Older Adults With Cancer
By: Allison Lipitz-Snyderman, Adam Klotz, Renee L. Gennarelli, and Jeffrey Groeger
Pages: 1234–1239
Bladder Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology
By: Philippe E. Spiess, Neeraj Agarwal, Rick Bangs, Stephen A. Boorjian, Mark K. Buyyounouski, Peter E. Clark, Tracy M. Downs, Jason A. Efstathiou, Thomas W. Flaig, Terence Friedlander, Richard E. Greenberg, Khurshid A. Guru, Noah Hahn, Harry W. Herr, Christopher Hoimes, Brant A. Inman, Masahito Jimbo, A. Karim Kader, Subodh M. Lele, Joshua J. Meeks, Jeff Michalski, Jeffrey S. Montgomery, Lance C. Pagliaro, Sumanta K. Pal, Anthony Patterson, Elizabeth R. Plimack, Kamal S. Pohar, Michael P. Porter, Mark A. Preston, Wade J. Sexton, Arlene O. Siefker-Radtke, Guru Sonpavde, Jonathan Tward, Geoffrey Wile, Mary A. Dwyer, and Lisa A. Gurski
Pages: 1240–1267
Clinical Significance of Histologic Variants of Bladder Cancer
By: Joshua I. Warrick
Pages: 1268–1274
Urothelial Carcinoma of the Bladder and the Rise of Immunotherapy
By: David D. Chism
Pages: 1277–1284
Admission or Observation? Population Health Is Here
By: James A. Stewart
Pages: 1285–1286
  • Collapse
  • Expand